1.
Cortelezzi A, Pasquini M, Sarina B, Bertani G, Grifoni F, Colombi M, Deliliers GL. A pilot study of low-dose subcutaneous alemtuzumab therapy for patients with hemotherapy-refractory chronic lymphocytic leukemia. Haematologica 2005; 90(3):410-412.